Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction.

By Audrey H Wu, Keith D. Aaronson, S. Bolling, F. Pagani, K. Welch, T. Koelling. Journal of the American College of Cardiology, 2005

680 citations recorded by the source corpus.

Subfields: Biomedical Engineering, Cardiology and Cardiovascular Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/c2000dd7b189b9795b1e5269d83777e0286f40c5

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

Citations in the corpus

2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2017, background): “DOI: 10.1161/CIR.0000000000000503 June 20/27, 2017 e1181 CLINICAL STATEM ENTS AND GUIDELINES heart�org/statements by using either “Search for Guidelines & Statements” or the “Browse by Topic” area� To purchase additional reprints, call 843-216-2533 or e-mail kelle�ramsay@ wolterskluwer�com� Expert p”
[2017 ESC/EACTS Guidelines for the management of valvular heart disease]. (2017, background): “Indications for surgery in secondary mitral regurgitation are particularly restrictive when concomitant revascularization is not an option, owing to significant operative mortality, high rates of recurrent mitral regurgitation and the absence of a proven survival benefit.(137,138) Percutaneous edge-”
Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). (2012, neutral): “Several methods can be used to determine the severity of MR. Planimetry of the regurgitant jet should be abandoned, as this measurement is poorly reproducible and depends on numerous factors.”
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2017, background): “Pant S, Patel NJ, Deshmukh A, et al. Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011.”
Guidelines on the management of valvular heart disease The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (2006, background): “Regarding prognosis, most studies failed to demonstrate improved long-term clinical outcome following surgical correction of secondary MR [148, 149].”
Use of stabilized inverse propensity scores as weights to directly estimate relative risk and its confidence intervals (2009, background): “One can first fit a propensity score model that includes many potential covariates, and then the outcome model only has to include the propensity score and a few covariates that have no association with treatment [3, 21].”